Mayer, E. L., Trapani, D., Kim, S. E., Faggen, M. G., Sinclair, N., Sanz-Altamira, P. M., Battelli, C., Berwick, S., Lo, K. S., Acevedo, J., Sinclair, S. J., Malcolm, A., Varella, L., Sammons, S. L., Schumer, S. T., Poorvu, P. D., Wallace, E., Pasternak, E., Tayob, N., Tolaney, S. M. (2025). The TRADE study: A phase 2 trial to assess the tolerability of abemaciclib dose escalation in early-stage HR+/HER2- breast cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.517